本站大部份資料在 2016 年後就未更新，若資料內無明確標示資料時間，請預設該資料為過時資料並斟酌使用，謝謝
From http://data.fda.gov.tw/frontsite/data/DataAction.do?method=doDetail&infoId=43
| 許可證字號 | 處方標示 | 成分名稱 | 含量描述 | 含量 | 含量單位 | |
|---|---|---|---|---|---|---|
| 1293495 | 衛署藥輸字第019715號 | EACH VIAL CONTAINS: | TEICOPLANIN | 200 | 200.0000000000 | MG |
| 1293496 | 衛署藥輸字第019716號 | EACH GM: | TOLNAFTATE | 97-103 | % | |
| 1293497 | 衛署藥輸字第019717號 | EACH GM: | INDAPAMIDE | 97.0-103.0 | % | |
| 1293498 | 衛署藥輸字第019719號 | PYRANTEL PAMOATE | PYRANTEL PAMOATE | 97.0-103 | % | |
| 1293499 | 衛署藥輸字第019720號 | :BI2O3=90.0+% | BISMUTH SUBCARBONATE | 90.0 | 90.0000000000 | % |
| 1293500 | 衛署藥輸字第019721號 | METHIONINE DL- | 98.5 | 98.5000000000 | % | |
| 1293501 | 衛署藥輸字第019722號 | :BI=71.5-74.5% | BISMUTH SUBNITRATE (BISMUTH NITRATE BASIC) | 71.5-74.5 | % | |
| 1293502 | 衛署藥輸字第019723號 | CALCIUM GLYCEROPHOSPHATE | 98.0 | 98.0000000000 | % | |
| 1293503 | 衛署藥輸字第019724號 | :BI=55.6-59.2% | BISMUTH SUBSALICYLATE | 55.6-59.2 | % | |
| 1293504 | 衛署藥輸字第019725號 | SALICYLAMIDE | 98.0 | 98.0000000000 | % | |
| 1293505 | 衛署藥輸字第019726號 | :JPX | ALBUMIN TANNATE (TANNALBIN) | 500 | 500.0000000000 | GM |
| 1293506 | 衛署藥輸字第019727號 | EACH CAPSULE CONTAINS: | ALFACALCIDOL | 0.25 | 0.2500000000 | MCG |
| 1293507 | 衛署藥輸字第019728號 | :AL2O3=33-43%;MGO=20-28% | MAGALDRATE | 43-20 | % | |
| 1293508 | 衛署藥輸字第019729號 | PHENYLEPHRINE HCL | 98.0-102.0 | % | ||
| 1293509 | 衛署藥輸字第019730號 | :JPX | ALUMINUM SILICATE | 500 | 500.0000000000 | GM |
| 1293510 | 衛署藥輸字第019731號 | TAURINE (EQ TO 2-AMINOETHANE SULFONIC ACID) | 98.5 | 98.5000000000 | % | |
| 1293511 | 衛署藥輸字第019732號 | ETILEFRIN HCL | 97.5-102.5 | % | ||
| 1293512 | 衛署藥輸字第019733號 | INOSITOL NIACINATE | 97 | 97.0000000000 | % | |
| 1293513 | 衛署藥輸字第019734號 | :BI=47.0-51.0% | BISMUTH SUBGALLATE | 47.0-51.0 | % | |
| 1293514 | 衛署藥輸字第019735號 | ETHENZAMIDE (ETHOXYBENZAMIDE) | 98.0 | 98.0000000000 | % | |
| 1293515 | 衛署藥輸字第019736號 | :HYOSCYAMINE=0.95-1.15% | HYOSCYAMINE | 0.95-1.15 | % | |
| 1293516 | 衛署藥輸字第019737號 | BENZOCAINE (ETHYL AMINOBENZOATE) | 99.0 | 99.0000000000 | % | |
| 1293517 | 衛署藥輸字第019738號 | INOSITOL (MESO-INOSITOL) | 97.0 | 97.0000000000 | % | |
| 1293518 | 衛署藥輸字第019739號 | NIACINAMIDE (NICOTINAMIDE) | 98.5 | 98.5000000000 | % | |
| 1293519 | 衛署藥輸字第019740號 | EACH TABLET (170MG) CONTAINS: | ISOSORBIDE DINITRATE | 20.00 | 20.0000000000 | MG |
| 1293520 | 衛署藥輸字第019741號 | EACH CAPSULE CONTAINS: | TOCOPHEROL ACETATE ALPHA DL- | 50 | 50.0000000000 | MG |
| 1293521 | 衛署藥製字第001999號 | EACH ML CONTAINS: | AMMONIUM CHLORIDE | 20 | 20.0000000000 | MG |
| 1293522 | 衛署藥製字第001999號 | EACH ML CONTAINS: | SODIUM CITRATE (SODIUM CITRATE TRIBASIC) | 10 | 10.0000000000 | MG |
| 1293523 | 衛署藥製字第001999號 | EACH ML CONTAINS: | CHLORPHENIRAMINE MALEATE | 0.4 | 0.4000000000 | MG |
| 1293524 | 衛署藥製字第001999號 | EACH ML CONTAINS: | PHENYLEPHRINE HCL | 2 | 2.0000000000 | MG |
| 1293525 | 衛署藥製字第002000號 | EACH TABLET CONTAINS: | TOCOPHEROL ALPHA DL- (EQ TO DL-ALPHA TOCOPHEROL) | 50.0000000000 | MG | |
| 1293526 | 衛署藥製字第002000號 | EACH TABLET CONTAINS: | THIAMINE TETRAHYDROFURFURYL DISULFIDE | 25.0000000000 | MG | |
| 1293527 | 衛署藥製字第002000號 | EACH TABLET CONTAINS: | RIBOFLAVIN (VIT B2) | 2.5000000000 | MG | |
| 1293528 | 衛署藥製字第002002號 | EACH TABLET CONTAINS: | CARBAZOCHROME SODIUM SULFONATE | 10 | 10.0000000000 | MG |
| 1293529 | 衛署藥製字第002007號 | EACH TABLET (150MG) CONTAINS: | BAMETHAN SULFATE | 12.5 | 12.5000000000 | MG |
| 1293530 | 衛署藥製字第002013號 | EACH TABLET (550MG) CONTAINS: | PROPYPHENAZONE (ISOPROPYPHENAZONE) | 100 | 100.0000000000 | MG |
| 1293531 | 衛署藥製字第002013號 | EACH TABLET (550MG) CONTAINS: | HYDROXYBUTYRIC ACID BETA- P-PHENETIDIDE (BUCETIN) | 100 | 100.0000000000 | MG |
| 1293532 | 衛署藥製字第002013號 | EACH TABLET (550MG) CONTAINS: | ETHENZAMIDE (ETHOXYBENZAMIDE) | 80 | 80.0000000000 | MG |
| 1293533 | 衛署藥製字第002636號 | EACH CAPSULE CONTAINS: | CLOXACILLIN (SODIUM) | 125 | 125.0000000000 | MG |
| 1293534 | 衛署藥製字第002637號 | EACH VIAL CONTAINS: | AMPICILLIN (SODIUM) | 250 | 250.0000000000 | MG |
| 1293535 | 衛署藥製字第002637號 | EACH VIAL CONTAINS: | CLOXACILLIN (SODIUM) | 250 | 250.0000000000 | MG |
| 1293536 | 衛署藥製字第002638號 | EACH CAPSULE CONTAINS: | CHLORAMPHENICOL | 250 | 250.0000000000 | MG |
| 1293537 | 衛署藥製字第002642號 | EACH CAPSULE 290MG CONTAINS: | AMPICILLIN (TRIHYDRATE) | 250 | 250.0000000000 | MG |
| 1293538 | 衛署藥製字第002644號 | EACH TABLET CONTAINS: | CHLORZOXAZONE | 250 | 250.0000000000 | MG |
| 1293539 | 衛署藥製字第002647號 | EACH TABLET (350MG) CONTAINS: | PANTOTHENATE CALCIUM | 33.3 | 33.3000000000 | MG |
| 1293540 | 衛署藥製字第002647號 | EACH TABLET (350MG) CONTAINS: | RIBOFLAVIN (VIT B2) | 3 | 3.0000000000 | MG |
| 1293541 | 衛署藥製字第002647號 | EACH TABLET (350MG) CONTAINS: | PYRIDOXINE HCL | 30 | 30.0000000000 | MG |
| 1293542 | 衛署藥製字第002647號 | EACH TABLET (350MG) CONTAINS: | NIACINAMIDE (NICOTINAMIDE) | 15 | 15.0000000000 | MG |
| 1293543 | 衛署藥輸字第017744號 | :USPXXI | CAFFEINE ANHYDROUS | 98.5-101.0 | % | |
| 1293544 | 衛署藥輸字第017745號 | :JP XI | DL-METHYLEPHEDRINE HCL | 99.0+ | % |